Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiang Pan

Showing results (471-480 of 528) with videos related to

Pageof 53
Sort By:
Blood Cancer Journal|August 27, 2024
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphomaBaoyan Bai, Jillian F Wise, Daniel Vodák, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Nature Communications|November 28, 2025
ZFP612 controls neuropathic pain through epigenetic repression of Il1rl1 within the silencer-promoter loop in primary sensory neurons of male miceLongfei Ma, Yangyuxin Huang, Meiling Han, et al.
Human Molecular Genetics|October 18, 2015
DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiencyTimo Volk, Ulrich Pannicke, Ismail Reisli, et al.
The Journal of Infectious Diseases|February 29, 2024
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19Benedikt Strunz, Christopher Maucourant, Adi Mehta, et al.
Blood|April 1, 2016
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomasKonstantinos Georgiou, Longyun Chen, Mattias Berglund, et al.
Blood Advances|June 10, 2022
Genomic characterization of lymphomas in patients with inborn errors of immunityXiaofei Ye, Paul J Maglione, Claudia Wehr, et al.
Iscience|May 31, 2023
ADAR1-mediated RNA editing promotes B cell lymphomagenesisRiccardo Pecori, Weicheng Ren, Mohammad Pirmoradian, et al.
Iscience|April 17, 2023
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concernMelissa García-Vega, Edgar A Melgoza-González, Sofía Hernández-Valenzuela, et al.
Nature Communications|May 13, 2022
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variantFanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Pageof 53

Showing results (471-480 of 528) with videos related to

Sort By:
Pageof 53
Blood Cancer Journal|August 27, 2024
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphomaBaoyan Bai, Jillian F Wise, Daniel Vodák, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Nature Communications|November 28, 2025
ZFP612 controls neuropathic pain through epigenetic repression of Il1rl1 within the silencer-promoter loop in primary sensory neurons of male miceLongfei Ma, Yangyuxin Huang, Meiling Han, et al.
Human Molecular Genetics|October 18, 2015
DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiencyTimo Volk, Ulrich Pannicke, Ismail Reisli, et al.
The Journal of Infectious Diseases|February 29, 2024
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19Benedikt Strunz, Christopher Maucourant, Adi Mehta, et al.
Blood|April 1, 2016
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomasKonstantinos Georgiou, Longyun Chen, Mattias Berglund, et al.
Blood Advances|June 10, 2022
Genomic characterization of lymphomas in patients with inborn errors of immunityXiaofei Ye, Paul J Maglione, Claudia Wehr, et al.
Iscience|May 31, 2023
ADAR1-mediated RNA editing promotes B cell lymphomagenesisRiccardo Pecori, Weicheng Ren, Mohammad Pirmoradian, et al.
Iscience|April 17, 2023
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concernMelissa García-Vega, Edgar A Melgoza-González, Sofía Hernández-Valenzuela, et al.
Nature Communications|May 13, 2022
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variantFanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Pageof 53